BGNO39 Stock Chart & Stats
$59.50
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$26.65 - $84.99
Previous CloseN/A
VolumeN/A
Average Volume (3M)109.00
Market Cap
R$1.88B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.13
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding31,680,000
10 Day Avg. Volume44
30 Day Avg. Volume109
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BGNO39 FAQ
What was Global X Genomics & Biotechnology’s price range in the past 12 months?
Global X Genomics & Biotechnology lowest stock price was $26.65 and its highest was $84.99 in the past 12 months.
What is Global X Genomics & Biotechnology’s market cap?
Global X Genomics & Biotechnology’s market cap is R$1.88B.
When is Global X Genomics & Biotechnology’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Global X Genomics & Biotechnology’s earnings last quarter?
Currently, no data Available
Is Global X Genomics & Biotechnology overvalued?
According to Wall Street analysts Global X Genomics & Biotechnology’s price is currently Undervalued.
Does Global X Genomics & Biotechnology pay dividends?
Global X Genomics & Biotechnology does not currently pay dividends.
What is Global X Genomics & Biotechnology’s EPS estimate?
Global X Genomics & Biotechnology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global X Genomics & Biotechnology have?
Global X Genomics & Biotechnology has 31,680,000 shares outstanding.
What happened to Global X Genomics & Biotechnology’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Global X Genomics & Biotechnology?
Currently, no hedge funds are holding shares in BR:BGNO39
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh
―
Biomm SA
―
Blau Farmaceutica SA
―
Oncoclinicas do Brasil Servicos Medicos SA
―
Profarma Distribuidora de Produtos Farmaceuticos SA
―